Female Pelvic Implants Market

Female Pelvic Implants Market: Companies to Focus on Reducing Cost of Implants to Gain Maximum Market Share: Global Industry Analysis 2012 - 2016 and Opportunity Assessment 2017 - 2027

Ask The Analyst Customization Available Request Methodology

Vaginal slings to hold an attractive spot in the global female pelvic implants market

Female Pelvic Implants is a procedure to treat disorders such as pelvic organ prolapse and stress urinary incontinence. The three main types of products or implants used in the procedure are vaginal mesh implants, vaginal sling and vaginal graft implants. Among these, vaginal slings are expected to hold the highest market value of over US$ 188 Mn by the end of 2027. These types of implants are generally made from a narrow ‘tape’ of polypropylene mesh that is placed under the urethra like a sling or hammock to keep the urethra in the correct position. Vaginal slings have been in the market for about 20 years and can be implanted in a half-hour, minimally invasive surgical procedure under local anaesthesia as an outpatient. Vaginal grafts are also expected to be an attractive product in the market and are expected to grow at a significant rate of 3.5% during the forecast period.

female-pelvic-implants-market.jpg

Alarming procedural failure rates to become a huge barrier in the growth of the female pelvic implants market

The female pelvic implants market is witnessing a sluggish growth mainly due to the increase in the number of complications in the implant procedures. According to the NHS data, thousands of women have undergone a surgery for removal of vaginal mesh implants since 2011. This explains the severity of traumatic complications associated with vaginal mesh. According to the NHS, 1 in 15 women who underwent surgery also required another surgery to remove mesh implants. There are also reports that over 75,000 procedures were performed in the U.K for removal of mesh implants during 2006–2016. Such failures have made people and medical experts lose trust on pelvic implants. The procedure is comparatively better than any other treatment option for disorders like SUI and POP; yet there is no existing data on the safe long-term use of mesh implants. This has resulted in considerable decrease in sales of SUI and POP implants over time and the trend is expected to continue unless the clinical efficiency and safety of these products is established.

Despite serious issues emerging due to complications in pelvic implants, surgeons support usage owing to the high cure rates

Due to non-availability of any other successful treatment process for SUI and POP, surgeons are supporting mesh and sling implants as these products come with a high cure rate as compared to traditional reconstructive surgery. According to the recent clinical studies for comparison between standard native tissue repair vs. prosthetic material implants, the group with prosthetic material implants showed better anatomical outcomes. Another major factor supporting the female pelvic implants market is that there is currently no implementation of a legal ban on the procedure. At present, there is no legal ban on these devices in matured markets of the U.S. and Europe, which is encouraging manufacturers to sell these devices in the global market. This gives evidence to surgeons as well as the general population that these devices are safe for use and thus patients and physicians are still opting for surgical mesh implant procedures, which is keeping up the global demand for pelvic implants.However, the landscape may change in the future if manufacturers fail to submit safety data requirements for pre-market approval of surgical mesh implants for trans-vaginal pelvic organ prolapse.

Global Healthcare Sector Outlook

Despite the economic and political uncertainty in the recent past, the global healthcare industry has been receiving positive nudges from reformative and technological disruptions in medical devices, pharmaceuticals and biotech, in-vitro diagnostics, and medical imaging. Key markets across the world are facing a massive rise in demand for critical care services that are pushing global healthcare spending levels to unimaginable limits.

A rapidly multiplying geriatric population; increasing prevalence of chronic ailments such as cancer and cardiac disease; growing awareness among patients; and heavy investments in clinical innovation are just some of the factors that are impacting the performance of the global healthcare industry. Proactive measures such as healthcare cost containment, primary care delivery, innovation in medical procedures (3-D printing, blockchain, and robotic surgery to name a few), safe and effective drug delivery, and well-defined healthcare regulatory compliance models are targeted at placing the sector on a high growth trajectory across key regional markets.

Parent Indicators Healthcare

  • Current expenditure on health, % of gross domestic product

  • Current expenditure on health, per capita, US$ purchasing power parities (current prices, current PPPs)

  • Annual growth rate of current expenditure on health, per capita, in real terms

  • Out-of-pocket expenditure, % of current expenditure on health

  • Out-of-pocket expenditure, per capita, US$ purchasing power parity (current prices, current PPPs)

  • Physicians, Density per 1000 population (head counts)

  • Nurses, Density per 1000 population (head counts)

  • Total hospital beds, per 1000 population

  • Curative (acute) care beds, per 1000 population

  • Medical technology, Magnetic Resonance Imaging units, total, per million population

  • Medical technology, Computed Tomography scanners, total, per million population

Research Methodology

FMI utilizes a triangulation methodology that is primarily based on experimental techniques such as patient-level data, number of procedures and capital equipment install base to obtain precise market estimations and insights on various medical devices and medical technology. Bottom-up approach is always used to obtain insightful data for the specific country/regions. The country specific data is again analysed to derive data at a global level. This methodology ensures high quality and accuracy of information.

Secondary research is used at the initial phase to identify the feasibility of the target products/technology categories and its respective segments, product offerings, usage pattern as per disease indications, product installed base in target healthcare facilities, life span of a device, reimbursement scenario, adoption rate and future impact of new technologies.

Each piece of information is eventually analysed during the entire research project which builds a strong base for the primary research information.

Primary research participants include demand-side users such as key opinion leaders, physicians, surgeons, and supply-side providers of medical devices who provide valuable insights on trends, key treatment patterns, adoption rate, and purchasing pattern, technological development of medical devices, patient education, effectiveness of manufacturers and important strategies, pricing and competitive dynamics.

Quantitative and qualitative assessment of basic factors driving demand, economic factors/cycles and growth rates and strategies utilized by key players in the market is analysed in detail while forecasting, in order to project Year-on-Year growth rates. These Y-o-Y growth projections are checked and aligned as per industry/product lifecycle and further utilized to develop market numbers at a holistic level.

On the other hand, we also analyse various companies annual reports, investor presentations, SEC filings, 10k reports and press release operating in this market segment to fetch substantial information about the market size, trends, opportunity, drivers, restraints and to analyse key players and their market shares. Key companies are segmented at tier level based on their revenues, product portfolio and presence.

Please note that these are the partial steps that are being followed while developing the market size. Besides this, forecasting will be done based on our internal proprietary model which also uses different macro-economic factors such as per capita healthcare expenditure, disposable income, industry based demand driving factors impacting the market and its forecast trends apart from disease related factors.

Key Questions Answered

  • How the market has performed over the past few years?

  • What have been the challenges for market participants and how did they overcome them?

  • How has the technology landscape evolved over the past years?

  • How the competitors have performed and what have been their growth strategies?

  • What is the market potential expected to look like in near future across the globe?

  • How to sustain and grow market share?

  • What should be the future course of action?

  • Where do I currently stand?

  • Which are the segments, factors, regions offering promising growth potential?

  • What are the trends in the market and am I ready for them?

Market Taxonomy

Product Type

Indication

 End User

 Region

  • Vaginal Mesh Implants

  • Vaginal Sling

  • Vaginal Graft Implants

  • Pelvic Organ Prolapse

  • Stress Urinary Incontinence

  • Hospitals

  • Ambulatory Surgical Centres

  • Speciality Clinics

  • North America

  • Latin America

  • China

  • Western Europe

  • Eastern Europe

  • APECJ

  • Japan

  • MEA

Female Pelvic Implants Market Reports - Table of Contents

1. Executive Summary

1.1. Overview

1.2. Market Analysis

1.3. FMI Analysis and Recommendations

1.4. Wheel of Fortune

2. Market Introduction

2.1. Market Taxonomy

2.2. Market Definition

3. Global Economic Outlook

3.1. Gross Domestic Product by Region & Country, 2006 – 2021

4. Female Pelvic Implants Market View point

4.1. Macro-Economic Factors

4.2. Market Dynamics

4.2.1. Drivers

4.2.2. Restraints

4.2.3. Opportunity Analysis

4.2.4. Trends

5. Regulatory Challenges & Legal Challenges

5.1. Future of the Market –Pelvic Organ Prolapse

6. North America Female Pelvic Implants Market Analysis 2012–2016 and Forecast 2017–2027

6.1. Introduction/Key Findings

6.2. Historical Market Size (US$ Mn) Analysis By Country, 2012–2016

6.2.1. U.S.

6.2.2. Canada

6.3. Market Size (US$ Mn) Forecast By Country, 2017–2027

6.4. Historical Market Size (US$ Mn) Analysis By Product Type, 2012–2016

6.4.1. Vaginal Mesh Implants

6.4.2. Vaginal Sling

6.4.3. Vaginal Graft Implants

6.5. Market Size (US$ Mn) Forecast By Product Type, 2017–2027

6.6. Historical Market Size (US$ Mn) Analysis By Indication Type, 2012–2016

6.6.1. Pelvic Organ Prolapse (POP)

6.6.2. Stress Urinary Incontinence (SUI)

6.7. Market Size (US$ Mn) Forecast By Indication Type, 2017–2027

6.8. Historical Market Size (US$ Mn) Analysis By End User, 2012–2016

6.8.1. Hospitals

6.8.2. Ambulatory Surgical Centers

6.8.3. Specialty Clinics

6.9. Market Size (US$ Mn) Forecast By End User, 2017–2027

6.10. Market Attractiveness Analysis

6.10.1. By Country

6.10.2. By Product Type

6.10.3. By Indication Type

6.10.4. By End User

6.11. Drivers and Restraints – Impact Analysis

7. Latin America Female Pelvic Implants Market Analysis 2012–2016 and Forecast 2017–2027

7.1. Introduction/Key Findings

7.2. Historical Market Size (US$ Mn) Analysis By Country, 2012–2016

7.2.1. Brazil

7.2.2. Mexico

7.2.3. Rest of Latin America

7.3. Market Size (US$ Mn) Forecast By Country, 2017–2027

7.4. Historical Market Size (US$ Mn) Analysis By Product Type, 2012–2016

7.4.1. Vaginal Mesh Implants

7.4.2. Vaginal Sling

7.4.3. Vaginal Graft Implants

7.5. Market Size (US$ Mn) Forecast By Product Type, 2017–2027

7.6. Historical Market Size (US$ Mn) Analysis By Indication Type, 2012–2016

7.6.1. Pelvic Organ Prolapse (POP)

7.6.2. Stress Urinary Incontinence (SUI)

7.7. Market Size (US$ Mn) Forecast By Indication Type, 2017–2027

7.8. Historical Market Size (US$ Mn) Analysis By End User, 2012–2016

7.8.1. Hospitals

7.8.2. Ambulatory Surgical Centers

7.8.3. Specialty Clinics

7.9. Market Size (US$ Mn) Forecast By End User, 2017–2027

7.10. Market Attractiveness Analysis

7.10.1. By Country

7.10.2. By Product Type

7.10.3. By Indication Type

7.10.4. By End User

7.11. Drivers and Restraints – Impact Analysis

8. Western Europe Female Pelvic Implants Market Analysis 2012–2016 and Forecast 2017–2027

8.1. Introduction/Key Findings

8.2. Historical Market Size (US$ Mn) Analysis By Country, 2012–2016

8.2.1. Germany

8.2.2. Italy

8.2.3. France

8.2.4. Spain

8.2.5. U.K.

8.2.6. BENELUX

8.2.7. Nordic

8.2.8. Rest of Western Europe

8.3. Market Size (US$ Mn) Forecast By Country, 2017–2027

8.4. Historical Market Size (US$ Mn) Analysis By Product Type, 2012–2016

8.4.1. Vaginal Mesh Implants

8.4.2. Vaginal Sling

8.4.3. Vaginal Graft Implants

8.5. Market Size (US$ Mn) Forecast By Product Type, 2017–2027

8.6. Historical Market Size (US$ Mn) Analysis By Indication Type, 2012–2016

8.6.1. Pelvic Organ Prolapse (POP)

8.6.2. Stress Urinary Incontinence (SUI)

8.7. Market Size (US$ Mn) Forecast By Indication Type, 2017–2027

8.8. Historical Market Size (US$ Mn) Analysis By End User, 2012–2016

8.8.1. Hospitals

8.8.2. Ambulatory Surgical Centers

8.8.3. Specialty Clinics

8.9. Market Size (US$ Mn) Forecast By End User, 2017–2027

8.10. Market Attractiveness Analysis

8.10.1. By Country

8.10.2. By Product Type

8.10.3. By Indication Type

8.10.4. By End User

8.11. Drivers and Restraints – Impact Analysis

9. Eastern Europe Female Pelvic Implants Market Analysis 2012–2016 and Forecast 2017–2027

9.1. Introduction/Key Findings

9.2. Historical Market Size (US$ Mn) Analysis By Country, 2012–2016

9.2.1. Russia

9.2.2. Poland

9.2.3. Rest of Eastern Europe

9.3. Market Size (US$ Mn) Forecast By Country, 2017–2027

9.4. Historical Market Size (US$ Mn) Analysis By Product Type, 2012–2016

9.4.1. Vaginal Mesh Implants

9.4.2. Vaginal Sling

9.4.3. Vaginal Graft Implants

9.5. Market Size (US$ Mn) Forecast By Product Type, 2017–2027

9.6. Historical Market Size (US$ Mn) Analysis By Indication Type, 2012–2016

9.6.1. Pelvic Organ Prolapse (POP)

9.6.2. Stress Urinary Incontinence (SUI)

9.7. Market Size (US$ Mn) Forecast By Indication Type, 2017–2027

9.8. Historical Market Size (US$ Mn) Analysis By End User, 2012–2016

9.8.1. Hospitals

9.8.2. Ambulatory Surgical Centers

9.8.3. Specialty Clinics

9.9. Market Size (US$ Mn) Forecast By End User, 2017–2027

9.10. Market Attractiveness Analysis

9.10.1. By Country

9.10.2. By Product Type

9.10.3. By Indication Type

9.10.4. By End User

9.11.Drivers and Restraints – Impact Analysis

10. Asia Pacific excluding China and Japan Female Pelvic Implants Market Analysis 2012–2016 and Forecast 2017–2027

10.1. Introduction/Key Findings

10.2. Historical Market Size (US$ Mn) Analysis By Country, 2012–2016

10.2.1. India

10.2.2. ASEAN

10.2.3. Australia and New Zealand

10.2.4. Rest of APEJ

10.3. Market Size (US$ Mn) Forecast By Country, 2017–2027

10.4. Historical Market Size (US$ Mn) Analysis By Product Type, 2012–2016

10.4.1. Vaginal Mesh Implants

10.4.2. Vaginal Sling

10.4.3. Vaginal Graft Implants

10.5. Market Size (US$ Mn) Forecast By Product Type, 2017–2027

10.6. Historical Market Size (US$ Mn) Analysis By Indication Type, 2012–2016

10.6.1. Pelvic Organ Prolapse (POP)

10.6.2. Stress Urinary Incontinence (SUI)

10.7. Market Size (US$ Mn) Forecast By Indication Type, 2017–2027

10.8. Historical Market Size (US$ Mn) Analysis By End User, 2012–2016

10.8.1. Hospitals

10.8.2. Ambulatory Surgical Centers

10.8.3. Specialty Clinics

10.9. Market Size (US$ Mn) Forecast By End User, 2017–2027

10.10. Market Attractiveness Analysis

10.10.1. By Country

10.10.2. By Product Type

10.10.3. By Indication Type

10.10.4. By End User

10.11. Drivers and Restraints – Impact Analysis

11. China Female Pelvic Implants Market Analysis 2012–2016 and Forecast 2017–2027

11.1. Introduction/Key Findings

11.2. Historical Market Size (US$ Mn) Analysis By Product Type, 2012–2016

11.2.1. Vaginal Mesh Implants

11.2.2. Vaginal Sling

11.2.3. Vaginal Graft Implants

11.3. Market Size (US$ Mn) Forecast By Product Type, 2017–2027

11.4. Historical Market Size (US$ Mn) Analysis By Indication Type, 2012–2016

11.4.1. Pelvic Organ Prolapse (POP)

11.4.2. Stress Urinary Incontinence (SUI)

11.5. Market Size (US$ Mn) Forecast By Indication Type, 2017–2027

11.6. Historical Market Size (US$ Mn) Analysis By End User, 2012–2016

11.6.1. Hospitals

11.6.2. Ambulatory Surgical Centers

11.6.3. Specialty Clinics

11.7. Market Size (US$ Mn) Forecast By End User, 2017–2027

11.8. Market Attractiveness Analysis

11.8.1. By Product Type

11.8.2. By Indication Type

11.8.3. By End User

11.9.Drivers and Restraints – Impact Analysis

12. Japan Female Pelvic Implants Market Analysis 2012–2016 and Forecast 2017–2027

12.1. Introduction/Key Findings

12.2. Historical Market Size (US$ Mn) Analysis By Product Type, 2012–2016

12.2.1. Vaginal Mesh Implants

12.2.2. Vaginal Sling

12.2.3. Vaginal Graft Implants

12.3. Market Size (US$ Mn) Forecast By Product Type, 2017–2027

12.4. Historical Market Size (US$ Mn) Analysis By Indication Type, 2012–2016

12.4.1. Pelvic Organ Prolapse (POP)

12.4.2. Stress Urinary Incontinence (SUI)

12.5. Market Size (US$ Mn) Forecast By Indication Type, 2017–2027

12.6. Historical Market Size (US$ Mn) Analysis By End User, 2012–2016

12.6.1. Hospitals

12.6.2. Ambulatory Surgical Centers

12.6.3. Specialty Clinics

12.7. Market Size (US$ Mn) Forecast By End User, 2017–2027

12.8. Market Attractiveness Analysis

12.8.1. By Product Type

12.8.2. By Indication Type

12.8.3. By End User

12.9. Drivers and Restraints – Impact Analysis

13. Middle East & Africa Female Pelvic Implants Market Analysis 2012–2016 and Forecast 2017–2027

13.1. Introduction/Key Findings

13.2. Historical Market Size (US$ Mn) Analysis By Country, 2012–2016

13.2.1. GCC Countries

13.2.2. South Africa

13.2.3. Rest of MEA

13.3. Market Size (US$ Mn) Forecast By Country, 2017–2027

13.4. Historical Market Size (US$ Mn) Analysis By Product Type, 2012–2016

13.4.1. Vaginal Mesh Implants

13.4.2. Vaginal Sling

13.4.3. Vaginal Graft Implants

13.5. Market Size (US$ Mn) Forecast By Product Type, 2017–2027

13.6. Historical Market Size (US$ Mn) Analysis By Indication Type, 2012–2016

13.6.1. Pelvic Organ Prolapse (POP)

13.6.2. Stress Urinary Incontinence (SUI)

13.7. Market Size (US$ Mn) Forecast By Indication Type, 2017–2027

13.8. Historical Market Size (US$ Mn) Analysis By End User, 2012–2016

13.8.1. Hospitals

13.8.2. Ambulatory Surgical Centers

13.8.3. Specialty Clinics

13.9. Market Size (US$ Mn) Forecast By End User, 2017–2027

13.10. Drivers and Restraints: Impact Analysis

13.11. Market Attractiveness Analysis

13.11.1. By Country

13.11.2. By Product Type

13.11.3. By Indication Type

13.11.4. By End User

13.12. Drivers and Restraints – Impact Analysis

14. Forecast Factors: Relevance and Impact

15. Market Structure Analysis

15.1. Market Structure by Tier of Companies

16. Competition Analysis

16.1. Competition Dashboard

16.2. Company Deep Dive

16.2.1. Johnson & Johnson

16.2.2. Coloplast A/S

16.2.3. Becton, Dickinson and Company (C.R. Bard, Inc.)

16.2.4. Boston Scientific Corporation

16.2.5. pfm medical ag

16.2.6. Cook Medical

16.2.7. Betatech Medical

16.2.8. Dipromed Srl

16.2.9. Promedon Group

16.2.10. Caldera Medical

17. Global Female Pelvic Implants Market Analysis 2012–2016 and Forecast 2017–2027, By Region

17.1. Introduction/Key Findings

17.2. Historical Market Size (US$ Mn) Trend Analysis By Region, 2012–2016

17.3. Market Size (US$ Mn) Forecast By Region, 2017–2027

17.3.1. North America

17.3.2. Latin America

17.3.3. Western Europe

17.3.4. Eastern Europe

17.3.5. Asia Pacific excluding Japan

17.3.6. Japan

17.3.7. China

17.3.8. Middle East & Africa

17.4. Market Attractiveness Analysis By Region

18. Global Female Pelvic Implants Market Analysis 2012–2016 and Forecast 2017–2027, By Product Type

18.1. Introduction/Key Findings

18.2. Historical Market Size (US$ Mn) and Trend Analysis By Product Type, 2012–2016

18.2.1. Vaginal Mesh Implants

18.2.2. Vaginal Sling

18.2.3. Vaginal Graft Implants

18.3. Market Size (US$ Mn) and Forecast By Product Type, 2017–2027

18.4. Market Attractiveness Analysis By Product Type

19. Global Female Pelvic Implants Market Analysis 2012–2016 and Forecast 2017–2027, By Indication Type

19.1. Introduction/Key Findings

19.2. Historical Market Size (US$ Mn) and Trend Analysis By Indication Type, 2012–2016

19.2.1. Pelvic Organ Prolapse (POP)

19.2.2. Stress Urinary Incontinence (SUI)

19.3. Market Size (US$ Mn) and Forecast By Indication Type, 2017–2027

19.4. Market Attractiveness Analysis By Indication Type

20. Global Female Pelvic Implants Market Analysis 2012–2016 and Forecast 2017–2027, By End User

20.1. Introduction/Key Findings

20.2. Historical Market Size (US$ Mn) and Trend Analysis By End User, 2012–2016

20.2.1. Hospitals

20.2.2. Ambulatory Surgical Centers

20.2.3. Specialty Clinics

20.3. Market Size (US$ Mn) and Forecast By End User, 2017–2027

20.4. Market Attractiveness Analysis By End User

21. Global Female Pelvic Implants Market Analysis 2012–2016 and Forecast 2017–2027

21.1. Market Size and Y-o-Y Growth

21.2. Absolute $ Opportunity

22. Research Methodology

Female Pelvic Implants Market Reports - List of Tables

Table 01: North America Female Pelvic Implants Market Size (US$ Mn) Analysis 2012-2016 and Forecast 2017-2027, By Country

Table 02: North America Female Pelvic Implants Market Size (US$ Mn) Analysis 2012-2016 and Forecast 2017-2027, By Product Type

Table 03: North America Female Pelvic Implants Market Size (US$ Mn) Analysis 2012-2016 and Forecast 2017-2027, By Indication

Table 04: North America Female Pelvic Implants Market Size (US$ Mn) Analysis 2012-2016 and Forecast 2017-2027, By End User

Table 05: North Female Pelvic Implants Market Size (US$ Mn) Analysis 2012-2016 and Forecast 2017-2027, By Country

Table 06: Latin America Female Pelvic Implants Market Size (US$ Mn) Analysis 2012-2016 and Forecast 2017-2027, By Product Type

Table 07: Latin America Female Pelvic Implants Market Size (US$ Mn) Analysis 2012-2016 and Forecast 2017-2027, By Indication

Table 08: Latin America Female Pelvic Implants Market Size (US$ Mn) Analysis 2012-2016 and Forecast 2017-2027, By End User

Table 09: Western Europe Female Pelvic Implants Market Size (US$ Mn) Analysis 2012-2016 and Forecast 2017-2027, By Country

Table 10: Western Europe Female Pelvic Implants Market Size (US$ Mn) Analysis 2012-2016 and Forecast 2017-2027, By Product Type

Table 11: Western Europe Female Pelvic Implants Market Size (US$ Mn) Analysis 2012-2016 and Forecast 2017-2027, By Indication

Table 12: Western Europe Female Pelvic Implants Market Size (US$ Mn) Analysis 2012-2016 and Forecast 2017-2027, By End User

Table 13: Eastern Europe Female Pelvic Implants Market Size (US$ Mn) Analysis 2012-2016 and Forecast 2017-2027, By Country

Table 14: Eastern Europe Female Pelvic Implants Market Size (US$ Mn) Analysis 2012-2016 and Forecast 2017-2027, By Product Type

Table 15: Eastern Europe Female Pelvic Implants Market Size (US$ Mn) Analysis 2012-2016 and Forecast 2017-2027, By Indication

Table 16: Eastern Europe Female Pelvic Implants Market Size (US$ Mn) Analysis 2012-2016 and Forecast 2017-2027, By End User

Table 17: Asia Pacific Excluding Japan & China Female Pelvic Implants Market Size (US$ Mn) Analysis 2012-2016 and Forecast 2017-2027, By Country

Table 18: Asia Pacific Excluding Japan & China Female Pelvic Implants Market Size (US$ Mn) Analysis 2012-2016 and Forecast 2017-2027, By Product Type

Table 19: Asia Pacific Excluding Japan & China Female Pelvic Implants Market Size (US$ Mn) Analysis 2012-2016 and Forecast 2017-2027, By Indication

Table 20: Asia Pacific Excluding Japan & China Female Pelvic Implants Market Size (US$ Mn) Analysis 2012-2016 and Forecast 2017-2027, By End User

Table 21: China Female Pelvic Implants Market Size (US$ Mn) Analysis 2012-2016 and Forecast 2017-2027, By Product Type

Table 22: China Female Pelvic Implants Market Size (US$ Mn) Analysis 2012-2016 and Forecast 2017-2027, By Indication

Table 23: China Female Pelvic Implants Market Size (US$ Mn) Analysis 2012-2016 and Forecast 2017-2027, By End User

Table 24: Japan Female Pelvic Implants Market Size (US$ Mn) Analysis 2012-2016 and Forecast 2017-2027, By Product Type

Table 25: Japan Female Pelvic Implants Market Size (US$ Mn) Analysis 2012-2016 and Forecast 2017-2027, By Indication

Table 26: Japan Female Pelvic Implants Market Size (US$ Mn) Analysis 2012-2016 and Forecast 2017-2027, By End User

Table 27: Middle East & Africa Female Pelvic Implants Market Size (US$ Mn) Analysis 2012-2016 and Forecast 2017-2027, By Country

Table 28: Middle East & Africa Female Pelvic Implants Market Size (US$ Mn) Analysis 2012-2016 and Forecast 2017-2027, By Product Type

Table 29: Middle East & Africa Female Pelvic Implants Market Size (US$ Mn) Analysis 2012-2016 and Forecast 2017-2027, By Indication

Table 30: Middle East & Africa Female Pelvic Implants Market Size (US$ Mn) Analysis 2012-2016 and Forecast 2017-2027, By End User

Table 31: Global Female Pelvic Implants Market Size (US$ Mn) Analysis 2012-2016 and Forecast 2017-2027, By Region

Table 32: Global Female Pelvic Implants Market Size (US$ Mn) Analysis 2012-2016 and Forecast 2017-2027, By Product Type

Table 33: Global Female Pelvic Implants Market Size (US$ Mn) Analysis 2012-2016 and Forecast 2017-2027, By Indication

Table 34: Global Female Pelvic Implants Market Size (US$ Mn) Analysis 2012-2016 and Forecast 2017-2027, By End User

Female Pelvic Implants Market Reports - List of Figures

Figure 01: Global Female Pelvic Implants Market Value Share By Product Type (2017 E)

Figure 02: Global Female Pelvic Implants Market Value Share By Indication (2017 E)

Figure 03: Global Female Pelvic Implants Market Value Share By End User (2017 E)

Figure 04: Global Female Pelvic Implants Market Value Share By Region (2017 E)

Figure 05: Global Healthcare Expenditure in US$ Tn (2013–2020)

Figure 06: North America Female Pelvic Implants Market Share, By Product Type (2017)

Figure 7: North America Female Pelvic Implants Market Share, By Indication (2017)

Figure 8: North America Female Pelvic Implants Market Share, By End User (2017)

Figure 9: North America Female Pelvic Implants Market Share, By Country (2017)

Figure 10: North America Female Pelvic Implants Market size (US$ Mn) 2017 & 2027

Figure 11: North America Female Pelvic Implants Market Size (US$ Mn) Analysis, 2012–2016,

Figure 12: North America Female Pelvic Implants Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027

Figure 13: U.S. Female Pelvic Implants Market Size (US$ Mn) Analysis, 2012–2016

Figure 14: U.S. Female Pelvic Implants Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027

Figure 15: Canada Female Pelvic Implants Market Size (US$ Mn) Analysis, 2012–2016

Figure 16: Canada Female Pelvic Implants Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027

Figure 17: North America Female Pelvic Implants Market Attractiveness Analysis, , By Country

Figure 18: North America Female Pelvic Implants Market Attractiveness Analysis, By Product Type

Figure 19: North America Female Pelvic Implants Market Attractiveness Analysis, By Indication

Figure 20: North America Female Pelvic Implants Market Attractiveness Analysis, By End User

Figure 21: Latin America Female Pelvic Implants Market Share, By Product Type (2017)

Figure 22: Latin America Female Pelvic Implants Market Share, By Indication (2017)

Figure 23: Latin America Female Pelvic Implants Market Share, By End User (2017)

Figure 24: Latin America Female Pelvic Implants Market Share, By Country (2017)

Figure 25: Latin America Female Pelvic Implants Market size (US$ Mn) 2017 & 2027

Figure 26: Latin America Female Pelvic Implants Market Size (US$ Mn) Analysis, 2012–2016,

Figure 27: Latin America Female Pelvic Implants Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027

Figure 28: Brazil Female Pelvic Implants Market Size (US$ Mn) Analysis, 2012–2016

Figure 29: Brazil Female Pelvic Implants Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027

Figure 30: Mexico Female Pelvic Implants Market Size (US$ Mn) Analysis, 2012–2016

Figure 31: Mexico Female Pelvic Implants Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027

Figure 32: Rest of Latin America Female Pelvic Implants Market Size (US$ Mn) Analysis, 2012–2016

Figure 33: Rest of Latin America Female Pelvic Implants Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027

Figure 34: Latin America Female Pelvic Implants Market Attractiveness Analysis, , By Country

Figure 35: Latin America Female Pelvic Implants Market Attractiveness Analysis, By Product Type

Figure 36: Latin America Female Pelvic Implants Market Attractiveness Analysis, By Indication

Figure 37: Latin America Female Pelvic Implants Market Attractiveness Analysis, By End User

Figure 38: Western Europe Female Pelvic Implants Market Share, By Product Type (2017)

Figure 39: Western Europe Female Pelvic Implants Market Share, By Indication (2017)

Figure 40: Western Europe Female Pelvic Implants Market Share, By End User (2017)

Figure 41: Western Europe Female Pelvic Implants Market Share, By Country (2017)

Figure 42: Western Europe Female Pelvic Implants Market size (US$ Mn) 2017 & 2027

Figure 43: Western Europe Female Pelvic Implants Market Size (US$ Mn) Analysis, 2012–2016,

Figure 44: Western Europe Female Pelvic Implants Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027

Figure 45: Germany Female Pelvic Implants Market Size (US$ Mn) Analysis, 2012–2016

Figure 46: Germany Female Pelvic Implants Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027

Figure 47: Italy Female Pelvic Implants Market Size (US$ Mn) Analysis, 2012–2016

Figure 48: Italy Female Pelvic Implants Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027

Figure 49: France Female Pelvic Implants Market Size (US$ Mn) Analysis, 2012–2016

Figure 50: France Female Pelvic Implants Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027

Figure 51: Spain Female Pelvic Implants Market Size (US$ Mn) Analysis, 2012–2016

Figure 52: Spain Female Pelvic Implants Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027

Figure 53: U.K. Female Pelvic Implants Market Size (US$ Mn) Analysis, 2012–2016

Figure 54: U.K. Female Pelvic Implants Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027

Figure 55: Benelux Female Pelvic Implants Market Size (US$ Mn) Analysis, 2012–2016

Figure 56: Benelux Female Pelvic Implants Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027

Figure 57: Nordic Female Pelvic Implants Market Size (US$ Mn) Analysis, 2012–2016

Figure 58: Nordic Female Pelvic Implants Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027

Figure 59: Rest of Western Europe Female Pelvic Implants Market Size (US$ Mn) Analysis, 2012–2016

Figure 60: Rest of Western Europe Female Pelvic Implants Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027

Figure 61: Western Europe Female Pelvic Implants Market Attractiveness Analysis, , By Country

Figure 62: Western Europe Female Pelvic Implants Market Attractiveness Analysis, By Product Type

Figure 63: Western Europe Female Pelvic Implants Market Attractiveness Analysis, By Indication

Figure 64: Western Europe Female Pelvic Implants Market Attractiveness Analysis, By End User

Figure 65: Eastern Europe Female Pelvic Implants Market Share, By Product Type (2017)

Figure 66: Eastern Europe Female Pelvic Implants Market Share, By Indication (2017)

Figure 67: Eastern Europe Female Pelvic Implants Market Share, By End User (2017)

Figure 68: Eastern Europe Female Pelvic Implants Market Share, By Country (2017)

Figure 69: Eastern Europe Female Pelvic Implants Market size (US$ Mn) 2017 & 2027

Figure 70: Eastern Europe Female Pelvic Implants Market Size (US$ Mn) Analysis, 2012–2016,

Figure 71: Eastern Europe Female Pelvic Implants Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027

Figure 72: Russia Female Pelvic Implants Market Size (US$ Mn) Analysis, 2012–2016

Figure 73: Russia Female Pelvic Implants Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027

Figure 74: Poland Female Pelvic Implants Market Size (US$ Mn) Analysis, 2012–2016

Figure 75: Poland Female Pelvic Implants Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027

Figure 76: Rest of Eastern Europe Female Pelvic Implants Market Size (US$ Mn) Analysis, 2012–2016

Figure 77: Rest of Eastern Europe Female Pelvic Implants Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027

Figure 78: Eastern Europe Female Pelvic Implants Market Attractiveness Analysis, , By Country

Figure 79: Eastern Europe Female Pelvic Implants Market Attractiveness Analysis, By Product Type

Figure 80: Eastern Europe Female Pelvic Implants Market Attractiveness Analysis, By Indication

Figure 81: Eastern Europe Female Pelvic Implants Market Attractiveness Analysis, By End User

Figure 82: Asia Pacific Excluding Japan & China Female Pelvic Implants Market Share, By Product Type (2017)

Figure 83: Asia Pacific Excluding Japan & China Female Pelvic Implants Market Share, By Indication (2017)

Figure 84: Asia Pacific Excluding Japan & China Female Pelvic Implants Market Share, By End User (2017)

Figure 85: Asia Pacific Excluding Japan & China Female Pelvic Implants Market Share, By Country (2017)

Figure 86: Asia Pacific Excluding Japan & China Female Pelvic Implants Market size (US$ Mn) 2017 & 2027

Figure 87: Asia Pacific Excluding Japan & China Female Pelvic Implants Market Size (US$ Mn) Analysis, 2012–2016,

Figure 88: Asia Pacific Excluding Japan & China Female Pelvic Implants Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027

Figure 89: India Female Pelvic Implants Market Size (US$ Mn) Analysis, 2012–2016

Figure 90: India Female Pelvic Implants Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027

Figure 91: ASEAN Female Pelvic Implants Market Size (US$ Mn) Analysis, 2012–2016

Figure 92: ASEAN Female Pelvic Implants Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027

Figure 93: Australia & New Zealand Female Pelvic Implants Market Size (US$ Mn) Analysis, 2012–2016

Figure 94: Australia & New Zealand Female Pelvic Implants Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027

Figure 95: Rest of APEJC Female Pelvic Implants Market Size (US$ Mn) Analysis, 2012–2016

Figure 96: Rest of APEJC Female Pelvic Implants Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027

Figure 97: Asia Pacific Excluding Japan & China Female Pelvic Implants Market Attractiveness Analysis, , By Country

Figure 98: Asia Pacific Excluding Japan & China Female Pelvic Implants Market Attractiveness Analysis, By Product Type

Figure 99: Asia Pacific Excluding Japan & China Female Pelvic Implants Market Attractiveness Analysis, By Indication

Figure 100: Asia Pacific Excluding Japan & China Female Pelvic Implants Market Attractiveness Analysis, By End User

Figure 101: China Female Pelvic Implants Market Share, By Product Type (2017)

Figure 102: China Female Pelvic Implants Market Share, By Indication (2017)

Figure 103: China Female Pelvic Implants Market Share, By End User (2017)

Figure 104: China Female Pelvic Implants Market size (US$ Mn) 2017 & 2027

Figure 105: China Female Pelvic Implants Market Size (US$ Mn) Analysis, 2012–2016,

Figure 106: China Female Pelvic Implants Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027

Figure 107: China Female Pelvic Implants Market Attractiveness Analysis, By Product Type

Figure 108: China Female Pelvic Implants Market Attractiveness Analysis, By Indication

Figure 109: China Female Pelvic Implants Market Attractiveness Analysis, By End User

Figure 110: Japan Female Pelvic Implants Market Share, By Product Type (2017)

Figure 111: Japan Female Pelvic Implants Market Share, By Indication (2017)

Figure 112: Japan Female Pelvic Implants Market Share, By End User (2017)

Figure 113: Japan Female Pelvic Implants Market size (US$ Mn) 2017 & 2027

Figure 114: Japan Female Pelvic Implants Market Size (US$ Mn) Analysis, 2012–2016,

Figure 115: Japan Female Pelvic Implants Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027

Figure 116: Japan Female Pelvic Implants Market Attractiveness Analysis, By Product Type

Figure 117: Japan Female Pelvic Implants Market Attractiveness Analysis, By Indication

Figure 118: Japan Female Pelvic Implants Market Attractiveness Analysis, By End User

Figure 119: Middle East & Africa Female Pelvic Implants Market Share, By Product Type (2017)

Figure 120: Middle East & Africa Female Pelvic Implants Market Share, By Indication (2017)

Figure 121: Middle East & Africa Female Pelvic Implants Market Share, By End User (2017)

Figure 122: Middle East & Africa Female Pelvic Implants Market Share, By Country (2017)

Figure 123: Middle East & Africa Female Pelvic Implants Market size (US$ Mn) 2017 & 2027

Figure 124: Middle East & Africa Female Pelvic Implants Market Size (US$ Mn) Analysis, 2012–2016,

Figure 125: Middle East & Africa Female Pelvic Implants Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027

Figure 126: GCC Countries Female Pelvic Implants Market Size (US$ Mn) Analysis, 2012–2016

Figure 127: GCC Countries Female Pelvic Implants Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027

Figure 128: South Africa Female Pelvic Implants Market Size (US$ Mn) Analysis, 2012–2016

Figure 129: South Africa Female Pelvic Implants Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027

Figure 130: Rest of Middle East & Africa Female Pelvic Implants Market Size (US$ Mn) Analysis, 2012–2016

Figure 131: Rest of Middle East & Africa Female Pelvic Implants Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027

Figure 132: Middle East & Africa Female Pelvic Implants Market Attractiveness Analysis, , By Country

Figure 133: Middle East & Africa Female Pelvic Implants Market Attractiveness Analysis, By Product Type

Figure 134: Middle East & Africa Female Pelvic Implants Market Attractiveness Analysis, By Indication

Figure 135: Middle East & Africa Female Pelvic Implants Market Attractiveness Analysis, By End User

Figure 136: Global Female Pelvic Implants Market Attractiveness Analysis, By Region

Figure 137: Global Female Pelvic Implants Market Attractiveness Analysis, By Product Type

Figure 138: Global Female Pelvic Implants Market Attractiveness Analysis, By Indication

Figure 139: Global Female Pelvic Implants Market Attractiveness Analysis, By End User

Figure 140: Global Female Pelvic Implants Historical Market Size and Y-o-Y, 2012 - 2016

Figure 141: Global Female Pelvic Implants Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027

Figure 142: Global Female Pelvic Implants Market Absolute $ Opportunity, 2012–2027